Search research articles
Contact Us
Filters
Showing results (81-90 of 119) with videos related to
Page
of 12
Sort By:
The Journal of Rheumatology
|
August 1, 2023
Proceedings of the Collaborative Research Network Meeting at the GRAPPA 2022 Annual Meeting
Beverly Cheok Kuan Ng, Deepak Jadon, Frank Behrens, et al.
Annals of the Rheumatic Diseases
|
September 30, 2019
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial
Philip J Mease, Josef S Smolen, Frank Behrens, et al.
Arthritis and Rheumatism
|
June 3, 2008
Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysis
Oliver Distler, Frank Behrens, David Pittrow, et al.
BMC Medical Genetics
|
August 25, 2017
Genome-wide association and targeted analysis of copy number variants with psoriatic arthritis in German patients
Steffen Uebe, Maria Ehrlicher, Arif Bülent Ekici, et al.
The New England Journal of Medicine
|
March 31, 2021
Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis
Iain B McInnes, Jaclyn K Anderson, Marina Magrey, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 1, 2023
Characterization of patients with psoriatic arthritis in dermatologic and rheumatologic care: analysis of two registries
Matthias Augustin, Lisa Lindner, Laura Kühl, et al.
The Journal of Rheumatology
|
July 9, 2008
Clinical and genetic registries in psoriatic disease
Dafna D Gladman, Proton Rahman, Gerald G Krueger, et al.
Autoimmunity Reviews
|
June 2, 2025
Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease
Thorben Witte, Ioanna Minopoulou, Norman Michael Drzeniek, et al.
The Lancet. Rheumatology
|
January 22, 2024
Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial
Michaela Koehm, Tanja Rossmanith, Ann C Foldenauer, et al.
Thrombosis and Haemostasis
|
August 21, 2024
A Phase 1b PK/PD Study to Demonstrate Antigen Elimination with RLYB212, A Monoclonal Anti-HPA-1a Antibody for FNAIT Prevention
Christof Geisen, Erika Fleck, Stephan Martin Gastón Schäfer, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 119) with videos related to
Sort By:
Page
of 12
The Journal of Rheumatology
|
August 1, 2023
Proceedings of the Collaborative Research Network Meeting at the GRAPPA 2022 Annual Meeting
Beverly Cheok Kuan Ng, Deepak Jadon, Frank Behrens, et al.
Annals of the Rheumatic Diseases
|
September 30, 2019
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial
Philip J Mease, Josef S Smolen, Frank Behrens, et al.
Arthritis and Rheumatism
|
June 3, 2008
Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysis
Oliver Distler, Frank Behrens, David Pittrow, et al.
BMC Medical Genetics
|
August 25, 2017
Genome-wide association and targeted analysis of copy number variants with psoriatic arthritis in German patients
Steffen Uebe, Maria Ehrlicher, Arif Bülent Ekici, et al.
The New England Journal of Medicine
|
March 31, 2021
Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis
Iain B McInnes, Jaclyn K Anderson, Marina Magrey, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 1, 2023
Characterization of patients with psoriatic arthritis in dermatologic and rheumatologic care: analysis of two registries
Matthias Augustin, Lisa Lindner, Laura Kühl, et al.
The Journal of Rheumatology
|
July 9, 2008
Clinical and genetic registries in psoriatic disease
Dafna D Gladman, Proton Rahman, Gerald G Krueger, et al.
Autoimmunity Reviews
|
June 2, 2025
Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease
Thorben Witte, Ioanna Minopoulou, Norman Michael Drzeniek, et al.
The Lancet. Rheumatology
|
January 22, 2024
Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial
Michaela Koehm, Tanja Rossmanith, Ann C Foldenauer, et al.
Thrombosis and Haemostasis
|
August 21, 2024
A Phase 1b PK/PD Study to Demonstrate Antigen Elimination with RLYB212, A Monoclonal Anti-HPA-1a Antibody for FNAIT Prevention
Christof Geisen, Erika Fleck, Stephan Martin Gastón Schäfer, et al.
Page
of 12